{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:33Z","timestamp":1792637013053,"version":"4.5.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,26]]},"abstract":"<jats:p>Neoplastic transformation requires the elimination of key tumor suppressors, which may result from E3 ligase-mediated proteasomal degradation. We previously demonstrated a key role for the E3 ubiquitin ligase E6AP in the regulation of promyelocytic leukemia protein (PML) stability and formation of PML nuclear bodies. Here, we report the involvement of the E6AP-PML axis in B-cell lymphoma development. A partial loss of E6AP attenuated Myc-induced B-cell lymphomagenesis. This tumor suppressive action was achieved by the induction of cellular senescence. B-cell lymphomas deficient for E6AP expressed elevated levels of PML and PML-nuclear bodies with a concomitant increase in markers of cellular senescence, including p21, H3K9me3, and p16. Consistently, PML deficiency accelerated the rate of Myc-induced B-cell lymphomagenesis. Importantly, E6AP expression was elevated in \u223c 60% of human Burkitt lymphomas, and down-regulation of E6AP in B-lymphoma cells restored PML expression with a concurrent induction of cellular senescence in these cells. Our findings demonstrate that E6AP-mediated down-regulation of PML-induced senescence is essential for B-cell lymphoma progression. This provides a molecular explanation for the down-regulation of PML observed in non-Hodgkin lymphomas, thereby suggesting a novel therapeutic approach for restoration of tumor suppression in B-cell lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2011-10-387647","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T05:49:44Z","timestamp":1339480184000},"page":"822-832","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":49,"title":["E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis"],"prefix":"10.1182","volume":"120","author":[{"given":"Kamil","family":"Wolyniec","sequence":"first","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Shortt","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Department of Clinical Haematology, Monash Medical Centre, Clayton, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara","family":"Levav-Cohen","sequence":"additional","affiliation":[{"name":"The Hebrew University Hadassah Medical School, Jerusalem, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Alsheich-Bartok","sequence":"additional","affiliation":[{"name":"The Hebrew University Hadassah Medical School, Jerusalem, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Louria-Hayon","sequence":"additional","affiliation":[{"name":"The Hebrew University Hadassah Medical School, Jerusalem, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Corneille","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Southern Health, Victoria, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone J.","family":"Woods","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Opat","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Monash Medical Centre, Clayton, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky W.","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Scott","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;"},{"name":"Department of Medical Biology, The University of Melbourne, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Segal","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pandolfi","sequence":"additional","affiliation":[{"name":"Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fox","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;"},{"name":"Department of Medical Biology, The University of Melbourne, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hui","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics and Neurobiology, Duke University School of Medicine, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Lowe","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Haupt","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Haupt","sequence":"additional","affiliation":[{"name":"Research Division, The Peter MacCallum Cancer Centre, East Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;"},{"name":"Department of Pathology, The University of Melbourne, Parkville, Australia; and"},{"name":"Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111821263170200_B1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/156800911794519716","article-title":"Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.","volume":"11","author":"Potts","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"2019111821263170200_B2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1081\/CNV-120030218","article-title":"Development of the proteasome inhibitor Velcade (Bortezomib).","volume":"22","author":"Adams","year":"2004","journal-title":"Cancer Invest"},{"issue":"23","key":"2019111821263170200_B3","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/jnci\/djq416","article-title":"MDM2 as a modifier gene in retinoblastoma.","volume":"102","author":"Cast\u00e9ra","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2019111821263170200_B4","first-page":"2231","article-title":"p53 Mutation and MDM2 amplification in human soft tissue sarcomas.","volume":"53","author":"Leach","year":"1993","journal-title":"Cancer Res"},{"issue":"6381","key":"2019111821263170200_B5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","article-title":"Amplification of a gene encoding a p53-associated protein in human sarcomas.","volume":"358","author":"Oliner","year":"1992","journal-title":"Nature"},{"issue":"3","key":"2019111821263170200_B6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.98.3.1218","article-title":"Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells.","volume":"98","author":"Hengstermann","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111821263170200_B7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"2019111821263170200_B8","first-page":"113","article-title":"Warts, cancer and ubiquitylation: lessons from the papillomaviruses.","volume":"117","author":"Howley","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"Pt 5","key":"2019111821263170200_B9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/BST0360797","article-title":"Ubiquitin ligase E6-AP and its role in human disease.","volume":"36","author":"Matentzoglu","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"2019111821263170200_B10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2091-9-S1-S4","article-title":"HPV E6, E6AP and cervical cancer.","volume":"9","author":"Beaudenon","year":"2008","journal-title":"BMC Biochem"},{"issue":"8","key":"2019111821263170200_B11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/cdd.2009.31","article-title":"E6AP promotes the degradation of the PML tumor suppressor.","volume":"16","author":"Louria-Hayon","year":"2009","journal-title":"Cell Death Differ"},{"issue":"10","key":"2019111821263170200_B12","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.","volume":"93","author":"Melnick","year":"1999","journal-title":"Blood"},{"issue":"3","key":"2019111821263170200_B13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/3073","article-title":"PML is essential for multiple apoptotic pathways.","volume":"20","author":"Wang","year":"1998","journal-title":"Nat Genet"},{"issue":"5356","key":"2019111821263170200_B14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.279.5356.1547","article-title":"Role of PML in cell growth and the retinoic acid pathway.","volume":"279","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"7092","key":"2019111821263170200_B15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature04809","article-title":"Identification of a tumour suppressor network opposing nuclear Akt function.","volume":"441","author":"Trotman","year":"2006","journal-title":"Nature"},{"issue":"4","key":"2019111821263170200_B16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jnci\/djh043","article-title":"Loss of the tumor suppressor PML in human cancers of multiple histologic origins.","volume":"96","author":"Gurrieri","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2019111821263170200_B17","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-07-2200","article-title":"Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.","volume":"103","author":"Gurrieri","year":"2004","journal-title":"Blood"},{"issue":"48","key":"2019111821263170200_B18","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/onc.2008.305","article-title":"Regulation of apoptosis by PML and the PML-NBs.","volume":"27","author":"Bernardi","year":"2008","journal-title":"Oncogene"},{"key":"2019111821263170200_B19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2741\/3256","article-title":"PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.","volume":"14","author":"Bourdeau","year":"2009","journal-title":"Front Biosci"},{"issue":"16","key":"2019111821263170200_B20","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1101\/gad.14.16.2015","article-title":"PML is induced by oncogenic ras and promotes premature senescence.","volume":"14","author":"Ferbeyre","year":"2000","journal-title":"Genes Dev"},{"issue":"1","key":"2019111821263170200_B21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1101\/gad.1975111","article-title":"Regulation of E2Fs and senescence by PML nuclear bodies.","volume":"25","author":"Vernier","year":"2011","journal-title":"Genes Dev"},{"issue":"1","key":"2019111821263170200_B22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans.","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2019111821263170200_B23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrc3057","article-title":"Pro-senescence therapy for cancer treatment.","volume":"11","author":"Nardella","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"2019111821263170200_B24","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","article-title":"The essence of senescence.","volume":"24","author":"Kuilman","year":"2010","journal-title":"Genes Dev"},{"issue":"6046","key":"2019111821263170200_B25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"issue":"1","key":"2019111821263170200_B26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(86)90361-2","article-title":"The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.","volume":"47","author":"Langdon","year":"1986","journal-title":"Cell"},{"issue":"7052","key":"2019111821263170200_B27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"issue":"20","key":"2019111821263170200_B28","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","article-title":"INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.","volume":"13","author":"Schmitt","year":"1999","journal-title":"Genes Dev"},{"issue":"6366","key":"2019111821263170200_B29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"issue":"47","key":"2019111821263170200_B30","doi-asserted-by":"crossref","first-page":"18507","DOI":"10.1073\/pnas.0806213105","article-title":"Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats.","volume":"105","author":"Herold","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"2019111821263170200_B31","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/onc.2009.101","article-title":"RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.","volume":"28","author":"Wolyniec","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"2019111821263170200_B32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.","volume":"167","author":"Harris","year":"1988","journal-title":"J Exp Med"},{"issue":"6299","key":"2019111821263170200_B33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"issue":"16","key":"2019111821263170200_B34","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia.","volume":"101","author":"Egle","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111821263170200_B35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2009-03-212670","article-title":"Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.","volume":"115","author":"Frenzel","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111821263170200_B36","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/cdd.2008.195","article-title":"Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.","volume":"16","author":"Michalak","year":"2009","journal-title":"Cell Death Differ"},{"issue":"3","key":"2019111821263170200_B37","first-page":"271","article-title":"Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.","volume":"3","author":"Langdon","year":"1988","journal-title":"Oncogene Res"},{"issue":"6","key":"2019111821263170200_B38","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/emboj\/cdg133","article-title":"Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis.","volume":"22","author":"Alt","year":"2003","journal-title":"EMBO J"},{"issue":"9","key":"2019111821263170200_B39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/onc.2009.423","article-title":"p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.","volume":"29","author":"Post","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"2019111821263170200_B40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2009.12.043","article-title":"Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.","volume":"17","author":"Reimann","year":"2010","journal-title":"Cancer Cell"},{"issue":"7128","key":"2019111821263170200_B41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","article-title":"Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.","volume":"445","author":"Xue","year":"2007","journal-title":"Nature"},{"issue":"5","key":"2019111821263170200_B42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.002","article-title":"CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.","volume":"18","author":"Rakhra","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111821263170200_B43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2584","article-title":"Tumour suppression by p53: the importance of apoptosis and cellular senescence.","volume":"219","author":"Zuckerman","year":"2009","journal-title":"J Pathol"},{"issue":"A","key":"2019111821263170200_B44","first-page":"219","article-title":"PML: An emerging tumor suppressor and a target with therapeutic potential.","volume":"7","author":"Reineke","year":"2009","journal-title":"Cancer Ther"},{"issue":"24","key":"2019111821263170200_B45","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1182\/blood-2010-04-280818","article-title":"Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.","volume":"116","author":"Happo","year":"2010","journal-title":"Blood"},{"issue":"15","key":"2019111821263170200_B46","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.4161\/cc.9.15.12521","article-title":"Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK\/STAT-mediated signaling.","volume":"9","author":"Hubackova","year":"2010","journal-title":"Cell Cycle"},{"issue":"1-2","key":"2019111821263170200_B47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.gene.2007.04.020","article-title":"Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging.","volume":"397","author":"Adams","year":"2007","journal-title":"Gene"},{"issue":"2","key":"2019111821263170200_B48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2007.05.034","article-title":"Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells.","volume":"27","author":"Ye","year":"2007","journal-title":"Mol Cell"},{"issue":"1","key":"2019111821263170200_B49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.devcel.2004.10.019","article-title":"Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA.","volume":"8","author":"Zhang","year":"2005","journal-title":"Dev Cell"},{"issue":"6","key":"2019111821263170200_B50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","article-title":"Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.","volume":"113","author":"Narita","year":"2003","journal-title":"Cell"},{"issue":"2","key":"2019111821263170200_B51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2006.05.041","article-title":"A CK2-dependent mechanism for degradation of the PML tumor suppressor.","volume":"126","author":"Scaglioni","year":"2006","journal-title":"Cell"},{"issue":"3","key":"2019111821263170200_B52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ccr.2010.08.008","article-title":"Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.","volume":"18","author":"Yang","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/4\/822\/1498947\/zh803012000822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/4\/822\/1498947\/zh803012000822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T08:22:47Z","timestamp":1714033367000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/4\/822\/105634\/E6AP-ubiquitin-ligase-regulates-PMLinduced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-387647","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}